PMI
Income statement / Annual
Last year (2024), Picard Medical Inc.'s total revenue was $4.39 M,
a decrease of 12.93% from the previous year.
In 2024, Picard Medical Inc.'s net income was -$21.06 M.
See Picard Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$4.39 M |
$5.04 M |
$4.11 M |
| Cost of Revenue |
$4.50 M
|
$7.35 M
|
$9.10 M
|
| Gross Profit |
-$112.00 K
|
-$2.31 M
|
-$4.99 M
|
| Gross Profit Ratio |
-0.03
|
-0.46
|
-1.21
|
| Research and Development Expenses |
$3.38 M
|
$2.21 M
|
$1.90 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.22 M
|
$10.98 M
|
$4.18 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.60 M
|
$13.19 M
|
$6.08 M
|
| Cost And Expenses |
$18.10 M
|
$20.55 M
|
$15.18 M
|
| Interest Income |
$0.00
|
$2.00 K
|
$9.00 K
|
| Interest Expense |
$3.07 M
|
$140.00 K
|
$5.00 K
|
| Depreciation & Amortization |
$543.00 K
|
$585.00 K
|
$545.00 K
|
| EBITDA |
-$17.46 M |
-$14.85 M |
-$10.61 M |
| EBITDA Ratio |
-3.98
|
-2.94
|
-2.58
|
| Operating Income Ratio |
-3.12
|
-3.07
|
-2.69
|
| Total Other Income/Expenses Net |
-$7.36 M
|
-$69.00 K
|
-$90.00 K
|
| Income Before Tax |
-$21.07 M
|
-$15.57 M
|
-$11.16 M
|
| Income Before Tax Ratio |
-4.8
|
-3.09
|
-2.71
|
| Income Tax Expense |
-$15.00 K
|
-$2.00 K
|
$11.00 K
|
| Net Income |
-$21.06 M
|
-$15.57 M
|
-$11.17 M
|
| Net Income Ratio |
-4.8
|
-3.09
|
-2.72
|
| EPS |
-0.33 |
-0.25 |
-0.18 |
| EPS Diluted |
-0.33 |
-0.25 |
-0.18 |
| Weighted Average Shares Out |
$72.06 M
|
$72.06 M
|
$72.06 M
|
| Weighted Average Shares Out Diluted |
$72.06 M
|
$72.06 M
|
$72.06 M
|
| Link |
|
|
|
